Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Atherosclerosis
Report Explores the Pipeline and Discusses Mechanisms of Action of Developmental Agents for the Treatment of Atherosclerosis
October 5th, 2007
Research and Markets has announced the addition of "Stakeholder Insight: Atherosclerosis - HDL, ApoA-I, Carotid MRI and 64-slice CT Offer Opportunities for Future Treatment" to their offering. Atherosclerosis generally begins in childhood and manifests clinically in mid-to-late adulthood. While the mortality from atherosclerotic conditions has declined significantly, in developed countries cardiovascular disease accounts for nearly 50% of all deaths, and within the next 15-20 years, is projected to surpass infectious diseases to become the leading cause of death worldwide. Keywords: Atherosclerosis,...
Source: Health Business Week (2007-10-05)
|
